TEDOVA: vaccine OSE2101 +/- pembrolizumab as maintenance in platinum-sensitive recurrent ovarian cancer: clinical trial protocol
by Kabirian, Rayan (Author)
, Tredan, Olivier (Author)
, Marmé, Frederik (Author)
, Paoletti, Xavier (Author)
, Eberst, Lauriane (Author)
, Lebreton, Coriolan (Author)
, La Motte Rouge, Thibault De (Author)
, Sabatier, Renaud (Author)
, Angelergues, Antoine (Author)
, Fabbro, Michel (Author)
, Gorp, Toon Van (Author)
, Mansi, Laura (Author)
, Gladieff, Laurence (Author)
, Kaczmarek, Emilie (Author)
, Alexandre, Jérôme (Author)
, Grellety, Thomas (Author)
, Favier, Laure (Author)
, Welz, Julia (Author)
, Frenel, Jean-Sébastien (Author)
, Leary, Alexandra (Author)
,
Call Number:
Loading…
Located:
Loading…
Article (Journal)
Online Resource